Introduction: Recently, the expression of micro ribonucleic acids (microRNAs) in peripheral blood and tissues in patients with chronic inflammatory bowel disease (IBD) has been studied as a biomarker for diagnosis and monitoring of activity.
Aim: The aim of this study is to evaluate the correlation between serum microribonucleic acid 29 (miR-29) expression and different clinical parameters: activity, severity and extent of disease in IBD patients.
Materials and Methods: Serum miR-29 expression was tested in 70 patients with IBD (35 with ulcerative colitis (UC), 35 patients with Crohn's disease (CD)) and 30 healthy control subjects through reverse transcriptase and real-time quantitative PCR (RT-qPCR).
Results: The group of patients showed a mean serum miR-29 expression of 1.69 for CD, 1.23 for UC and 1.07 for the control group with a significant difference in expression between the groups.
Conclusion: There is a significant relation between increased serum miR-29 expression and disease activity, severity and extent in patients with UC.
Blenkiron C, Miska EA. 2007. miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum Mol Genet 16 Spec No 1:R106–R113
Brain O,Owens BM,Pichulik T,Allan P,Khatamzas E,Leslie A,Steevels T,Sharma S,Mayer A,Catuneanu AM.The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release. Immunity.2013;39:521-536
Chuang AY,Chuang JC,Zhai Z,Wu F,Kwon JH.NOD2 expression is regulated by microRNAs in colonic epithelial HCT116 cells. Inflamm Bowel Dis.2014;20:126-135
Cushing L, Kuang P, Lü J. The role of miR-29 in pulmonary fibrosis. Biochem Cell Biol 2015;93(2):109–18. doi: 10.1139/bcb-2014-0095
Du T, Zamore PD. 2007. Beginning to understand microRNA function. Cell Res 17(8):661–663
Fasseu M, Treton X, Guichard C, et al. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One 2010; 5:e13160
Liu JK., Lichtenstein GR. Chapter 21 - Inflammatory Bowel Disease. Clinical Gastrointestinal Endoscopy (Second Edition). 2012, 243-264
Mantzaris G. Mucosal healing. State of the art lecture. 35th ECCO Educational Workshop.ECCO Guidelines. 13 June 2014, Sofia
Paraskevi A, Theodoropoulos G, Papaconstantinou I, et al. Circulating microRNA in inflammatory bowel disease. J Crohns Colitis 2012; 6:900–904
Poy MN, Spranger M, Stoffel M. 2007. microRNAs and the regulation of glucose and lipid metabolism. Diabetes Obes Metab 9 Suppl 2:67–73
Rane S, Sayed D, Abdellatif M. 2007. MicroRNA with a MacroFunction. Cell Cycle 6(15):1850–1855
Rehman A, Sina C, Gavrilova O, Häsler R, Ott S, Baines JF, et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011;60(10):1354–62. doi: 10.1136/gut.2010.216259
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis.Part 2: Current management. Journal of Crohn`s and colitis (2012)6, 991-1030
Seiderer J, Brand S, Herrmann KA, Schnitzler F, Hatz R, Crispin A, et al. Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn’s disease in clinical practice: results of a prospective study. Inflamm Bowel Dis 2006;12(12):1114–21. doi: 10.1097/01. mib.0000235836.32176.5e
van Rooij E, Olson EN. 2007. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117(9):2369–2376
Wang LG, Gu J. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol 2012;36:e61–7
Wu F, Zikusoka M, Trindade A, et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008; 135:1624–1635
Xu XM, Zhang HJ. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation. World J Gastroenterol. 2016 Feb 21;22(7):2206-18. doi: 10.3748/wjg.v22.i7.2206
Zeng Z, Mukherjee A, Zhang H. From Genetics to Epigenetics, Roles of Epigenetics in Inflammatory Bowel Disease. Front Genet. 2019;10:1017. Published 2019 Oct 31. doi:10.3389/fgene.2019.01017
Zhu, Y., Xu, A., Li, J., Fu, J., Wang, G., Yang, Y., et al. (2016). Fecal miR-29a and miR-224 as the noninvasive biomarkers for colorectal cancer. Cancer Biomark. 16, 259–264. doi: 10.3233/CBM-150563
